BioNTech Total Assets from 2010 to 2024

BNTX Stock

USD 108.73 1.91 1.73%

BioNTech Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2018-12-31

Previous Quarter

22.3 B

Current Value

22.2 B

Quarterly Volatility

10 B

Covid

Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.71, Dividend Yield of 0.0111 or PTB Ratio of 1.19. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.

Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Total Assets Growth Pattern

Below is the plot of the Total Assets of BioNTech SE over the last few years. Total assets refers to the total amount of BioNTech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BioNTech SE books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. BioNTech's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 23.01 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

BioNTech Total Assets Regression Statistics

	Arithmetic Mean	6,209,766,267
	Geometric Mean	1,381,259,143
	Coefficient Of Variation	157.23
	Mean Deviation	8,191,166,658
	Median	389,959,000
	Standard Deviation	9,763,591,893
	Sample Variance	95327726.7T
	Range	23.8B
	R-Value	0.79
	Mean Square Error	38001571.2T
	R-Squared	0.63
	Significance	0.0004
	Slope	1,732,636,046
	Total Sum of Squares	1334588173.2T

BioNTech Total Assets History

	2024	24.2 B
	2023	23 B
	2022	23.3 B
	2021	15.8 B
	2020	2.3 B
	2019	797.6 M
	2018	653 M

Other Fundumenentals of BioNTech SE

Intangibles To Total Assets

BioNTech Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Long Term Investments	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.62	-0.93	0.99	0.94	0.69	0.82	0.76	0.86	0.75	1.0	0.58	0.81	0.67	1.0	1.0	0.86
Total Stockholder Equity	1.0		0.62	-0.95	1.0	0.95	0.65	0.83	0.78	0.84	0.78	0.99	0.53	0.83	0.66	1.0	1.0	0.85
Current Deferred Revenue	0.62	0.62		-0.53	0.6	0.8	0.27	0.79	0.74	0.49	0.72	0.59	0.33	0.78	0.72	0.62	0.6	0.85
Net Debt	-0.93	-0.95	-0.53		-0.95	-0.88	-0.44	-0.78	-0.72	-0.69	-0.74	-0.92	-0.26	-0.77	-0.58	-0.94	-0.94	-0.78
Retained Earnings	0.99	1.0	0.6	-0.95		0.95	0.61	0.85	0.8	0.81	0.8	0.99	0.49	0.84	0.62	1.0	0.99	0.83
Accounts Payable	0.94	0.95	0.8	-0.88	0.95		0.5	0.94	0.9	0.73	0.89	0.92	0.46	0.94	0.71	0.95	0.93	0.89
Net Receivables	0.69	0.65	0.27	-0.44	0.61	0.5		0.25	0.17	0.92	0.15	0.72	0.95	0.25	0.52	0.65	0.68	0.55
Good Will	0.82	0.83	0.79	-0.78	0.85	0.94	0.25		0.99	0.51	0.99	0.78	0.26	0.99	0.54	0.83	0.8	0.8
Short Term Investments	0.76	0.78	0.74	-0.72	0.8	0.9	0.17	0.99		0.43	1.0	0.71	0.19	0.99	0.46	0.77	0.74	0.73
Total Liab	0.86	0.84	0.49	-0.69	0.81	0.73	0.92	0.51	0.43		0.41	0.89	0.85	0.5	0.67	0.84	0.86	0.77
Long Term Investments	0.75	0.78	0.72	-0.74	0.8	0.89	0.15	0.99	1.0	0.41		0.71	0.16	0.99	0.45	0.77	0.74	0.71
Total Current Assets	1.0	0.99	0.59	-0.92	0.99	0.92	0.72	0.78	0.71	0.89	0.71		0.6	0.77	0.66	0.99	1.0	0.84
Short Term Debt	0.58	0.53	0.33	-0.26	0.49	0.46	0.95	0.26	0.19	0.85	0.16	0.6		0.26	0.52	0.54	0.56	0.51
Intangible Assets	0.81	0.83	0.78	-0.77	0.84	0.94	0.25	0.99	0.99	0.5	0.99	0.77	0.26		0.59	0.83	0.79	0.79
Common Stock	0.67	0.66	0.72	-0.58	0.62	0.71	0.52	0.54	0.46	0.67	0.45	0.66	0.52	0.59		0.66	0.66	0.84
Net Invested Capital	1.0	1.0	0.62	-0.94	1.0	0.95	0.65	0.83	0.77	0.84	0.77	0.99	0.54	0.83	0.66		1.0	0.86
Net Working Capital	1.0	1.0	0.6	-0.94	0.99	0.93	0.68	0.8	0.74	0.86	0.74	1.0	0.56	0.79	0.66	1.0		0.85
Capital Stock	0.86	0.85	0.85	-0.78	0.83	0.89	0.55	0.8	0.73	0.77	0.71	0.84	0.51	0.79	0.84	0.86	0.85

Click cells to compare fundamentals

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	23 B	24.2 B
Intangibles To Total Assets	0.05	0.09

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
CRM	Salesforce
S	SentinelOne

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC